絞り込み

17379

広告

Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis.

著者 Larkin J , Chmielowski B , Lao CD , Hodi FS , Sharfman W , Weber J , Suijkerbuijk KPM , Azevedo S , Li H , Reshef D , Avila A , Reardon DA
Oncologist.2017 May 11 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (64view , 0users)

Full Text Sources

Medical

Other Literature Sources

Despite unprecedented efficacy across multiple tumor types, immune checkpoint inhibitor therapy is associated with a unique and wide spectrum of immune-related adverse events (irAEs), including neurologic events ranging from mild headache to potentially life-threatening encephalitis. Here, we summarize neurologic irAEs associated with nivolumab and ipilimumab melanoma treatment, present cases of treatment-related encephalitis, and provide practical guidance on diagnosis and management.
PMID: 28495807 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード